fda warning letters compounded semaglutide tirzepatide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA and Novo Nordisk Warned

Sattar N, McGuire DK, Pavo I, Weerakkody GJ, Nishiyama H, Wiese RJ, Zoungas S

Patients frequently experience improved cardiovascular health, better blood sugar control, reduced joint pain, and enhanced energy and mobility

Although Ozempic was originally developed for type 2 diabetes, medications such as Wegovy and Ozempic are also prescribed for weight loss in non-diabetic individuals

Product: How to Store Tirzepatide: Tips for Proper Refrigeration Proper storage of tirzepatide ( is essential to preserve its efficacy and ensure patient safety

There is no way to get semaglutide, marketed under the brand names Ozempic and Wegovy, without a prescription